Advocacy In Action
Addiction Medicine Advocacy Conference: Bringing it Home 2026
Local Voices. National Change.
Join addiction treatment professionals from across the country for a hybrid advocacy experience designed to bring policy impact closer to home. The 2026 Addiction Medicine Advocacy Conference (AMAC) will equip attendees with the tools, messaging, and confidence to engage with members of Congress and their staff in local district offices during the August 2026 recess. Through a virtual, expert-led skills training in July 2026 and state-based networking, attendees will gain everything they need to advance a national policy agenda that supports addiction treatment professionals as they care for patients and save lives at home.
2025 Highlights
Nearly 100 ASAM members and addiction medicine experts convened in Washington, DC, for AMAC 2025. These advocates participated in 149 meetings on Capitol Hill with lawmakers and their staff to urge them to act on legislation that would advance addiction recovery in America. Priority legislation included:
- The Modernizing Opioid Treatment Access Act (MOTAA), which would allow addiction specialist physicians to prescribe methadone for opioid use disorder treatment that could be picked up at community pharmacies, subject to federal rules or guidance on supply of methadone for unsupervised use.
- The Residential Recovery for Seniors Act (RRSA), which would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment.
Catch the highlights from our recent event here and learn more about the policy priorities here.
